Liminatus Pharma, Inc. (LIMNW) SEC Filings — 2025
15 SEC filings for Liminatus Pharma, Inc. (LIMNW) in 2025.
Filings
- Liminatus Pharma Faces Delisting Concerns — 8-K · Nov 25, 2025
- Liminatus Pharma's Q3 Loss Widens Amid Post-Merger Operational Surge — 10-Q · Nov 14, 2025
- Liminatus Pharma Narrows H1 Loss Post-Merger, Raises Going Concern Doubts — 10-Q · Oct 6, 2025
- Liminatus Pharma Faces Delisting Notice — 8-K · Aug 25, 2025
- Liminatus Pharma Files 8-K — 8-K · Aug 14, 2025
- Liminatus Pharma's S-1/A Reveals Growing Deficit Amidst Restructuring — S-1/A · Jul 28, 2025
- Liminatus Pharma Enters Material Definitive Agreement — 8-K · Jul 17, 2025
- Liminatus Pharma Announces Board and Officer Changes — 8-K · Jul 11, 2025
- Liminatus Pharma to Raise $2.4M via Stock and Warrant Offering — 8-K · Jul 3, 2025
- Liminatus Pharma Files 8-K — 8-K · Jun 24, 2025
- Liminatus Pharma S-1 Reveals Deep Deficits, Related Party Ties — S-1 · Jun 24, 2025
- Liminatus Pharma Faces Delisting Concerns — 8-K · Jun 4, 2025
- Liminatus Pharma Files 8-K/A Amendment — 8-K/A · Jun 2, 2025
- Liminatus Pharma Issues 1M Shares to CEO, Warrants in Q1 — 10-Q · Jun 2, 2025
- Liminatus Pharma Completes Iris Parent Acquisition — 8-K · May 6, 2025